Putnam Investments’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-74,819
| Closed | -$1.29M | – | 1148 |
|
|
2017
Q1 | $1.29M | Sell |
74,819
-1,289,673
| -95% | -$22.3M | ﹤0.01% | 951 |
|
|
2016
Q4 | $15M | Sell |
1,364,492
-5,309
| -0.4% | -$58.3K | 0.04% | 316 |
|
|
2016
Q3 | $21.5M | Buy |
1,369,801
+1,044,801
| +321% | +$16.4M | 0.05% | 266 |
|
|
2016
Q2 | $3.32M | Hold |
325,000
| – | – | 0.01% | 789 |
|
|
2016
Q1 | $4.19M | Hold |
325,000
| – | – | 0.01% | 700 |
|
|
2015
Q4 | $6.78M | Buy |
+325,000
| New | +$6.78M | 0.02% | 563 |
|